Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ injury. Renal or cardiac involvement is most common, though any organ outside the central nervous system can develop amyloid d...
Main Authors: | Christopher E. Jensen, Mirnela Byku, Gerald A. Hladik, Koyal Jain, Rebecca E. Traub, Sascha A. Tuchman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.907584/full |
Similar Items
-
Renal-limited AL amyloidosis – a diagnostic and management dilemma
by: Kar Wah Fuah, et al.
Published: (2018-11-01) -
Kidney-limited AL amyloidosis: a case report and review of the literature
by: Sara Velayati, et al.
Published: (2021-09-01) -
Hypothyroidism Due to Thyroid Amyloidosis Simultaneously With AL Renal Amyloidosis to Give Better Idea of Association of the Two Conditions
by: Guan C, et al.
Published: (2025-01-01) -
Systemic Amyloidosis with Cardiac Involvement: Features of Course and Diagnostic Difficulties
by: E. V. Voloshinova, et al.
Published: (2024-08-01) -
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01)